Isolation, Characterization, Moisturization and Anti-HepG2 Cell Activities of a Novel Polysaccharide from Cyanobacterium aponinum
Molecules · 25.09.2024 · 29 (19) · 4556
DOI: 10.3390/molecules29194556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 25.09.2024. Verfasst von Zishuo Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Tropical Marine Bio-Resources and Ecology, Guangdong Key Laboratory of Marine Materia Medica, Institution of South China Sea Ec…. Hauptthemen laut MEDLINE: Cyanobacteria. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Nansha District Science and Technology Program.
Abstract (Originalsprache)
Polysaccharides from cyanobacteria are extensively reported for their complex structures, good biocompatibility, and diverse bioactivities, but only a few cyanobacterial species have been exploited for the biotechnological production of polysaccharides. According to our previous study, the newly isolated marine cyanobacterium Cyanobacterium aponinum SCSIO-45682 was a good candidate for polysaccharide production. This work provided a systematic study of the extraction optimization, isolation, structural characterization, and bioactivity evaluation of polysaccharides from C. aponinum SCSIO-45682. Results showed that the crude polysaccharide yield of C. aponinum reached 17.02% by hot water extraction. The crude polysaccharides showed a porous and fibrous structure, as well as good moisture absorption and retention capacities comparable to that of sodium alginate. A homogeneous polysaccharide (Cyanobacterium aponinum polysaccharide, CAP) was obtained after cellulose DEAE-52 column and Sephadex G-100 column purification. CAP possessed a high molecular weight of 4596.64 kDa. It was mainly composed of fucose, galactose, and galacturonic acid, with a molar ratio of 15.27:11.39:8.64. The uronic acid content and sulfate content of CAP was 12.96% and 18.06%, respectively. Furthermore, CAP showed an in vitro growth inhibition effect on human hepatocellular carcinoma (HepG2) cells. The above results indicated the potential of polysaccharides from the marine cyanobacterium C. aponinum SCSIO-45682 as a moisturizer and anticancer addictive applied in cosmetical and pharmaceutical industries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory of Tropical Marine Bio-Resources and Ecology, Guangdong Key Laboratory of Marine Materia Medica, Institution of South China Sea Ecology and Environmental Engineering, RNAM Center for Marine Microbiolo…
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Greater Bay Area Institute of Precision Medicine (Guangzhou), Guangzhou 511466, China.
- School of Basic Medical Sciences, Heyang Medical School, University of South China, Hengyang 421001, China.
ORCID-Profile: Wenzhou Xiang
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Nansha District Science and Technology Program
Zitieren
APA
Chen, Z., Wu, J., Wang, N., Li, T., Wu, H., Wu, H., & Xiang, W. (2024). Isolation, Characterization, Moisturization and Anti-HepG2 Cell Activities of a Novel Polysaccharide from Cyanobacterium aponinum. Molecules, 29(19), 4556. https://doi.org/10.3390/molecules29194556
Vancouver
Chen Z, Wu J, Wang N, Li T, Wu H, Wu H, et al. Isolation, Characterization, Moisturization and Anti-HepG2 Cell Activities of a Novel Polysaccharide from Cyanobacterium aponinum. Molecules. 2024;29(19):4556. doi:10.3390/molecules29194556
BibTeX
@article{Chen2024,
author = {Chen, Zishuo and Wu, Jiayi and Wang, Na and Li, Tao and Wu, Houbo and Wu, Hualian and Xiang, Wenzhou},
title = {Isolation, Characterization, Moisturization and Anti-HepG2 Cell Activities of a Novel Polysaccharide from Cyanobacterium aponinum},
journal = {Molecules},
year = {2024},
volume = {29},
number = {19},
pages = {4556},
doi = {10.3390/molecules29194556}
}
EUVIMED